Fasting, Intermittent
11
2
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences
Cognitive and Psychomotor Skills and Behavioural Changes During Ramadan in Women
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Time-Restricted Eating to Address Persistent Cancer-Related Fatigue
Ramadan Fasting in Secondary Adrenal Insufficiency Patients
Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Interactions of Medicine and Exercise With Meal Timing
Electrophysiological Changes With Diet.
Effect of Intermittent Fasting (Month of Ramadan) on Health
Fasting Time Effects in Time-Restricted Eating (FaTE-TRE)